{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:06:32Z","timestamp":1781622392625,"version":"3.54.5"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.canlet.2006.12.022","type":"journal-article","created":{"date-parts":[[2007,1,27]],"date-time":"2007-01-27T12:13:59Z","timestamp":1169900039000},"page":"30-39","source":"Crossref","is-referenced-by-count":94,"title":["Prostate-specific antigen in clinical practice"],"prefix":"10.1016","volume":"249","author":[{"given":"Stacy","family":"Loeb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Catalona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2006.12.022_bib1","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0094-0143(21)00921-6","article-title":"PSA-detected (clinical stage T1c or B0) prostate cancer. Pathologically significant tumors","volume":"20","author":"Oesterling","year":"1993","journal-title":"Urol. Clin. North Am."},{"key":"10.1016\/j.canlet.2006.12.022_bib2","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0022-5347(17)43543-9","article-title":"Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer","volume":"138","author":"Ercole","year":"1987","journal-title":"J. Urol."},{"key":"10.1016\/j.canlet.2006.12.022_bib3","first-page":"322","article-title":"Some physico-chemical characteristics of \u201c\u03b3-seminoprotein\u201d, an antigenic component specific for human seminal plasma. Forensic immunological study of body fluids and secretion. VII","volume":"25","author":"Hara","year":"1971","journal-title":"Nihon Hoigaku Zasshi"},{"key":"10.1016\/j.canlet.2006.12.022_bib4","first-page":"159","article-title":"Purification of a human prostate specific antigen","volume":"17","author":"Wang","year":"1979","journal-title":"Invest. Urol."},{"key":"10.1016\/j.canlet.2006.12.022_bib5","first-page":"2428","article-title":"A prostate antigen in sera of prostatic cancer patients","volume":"40","author":"Papsidero","year":"1980","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2006.12.022_bib6","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1056\/NEJM198710083171501","article-title":"Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate","volume":"317","author":"Stamey","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2006.12.022_bib7","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM199104253241702","article-title":"Measurement of prostate-specific antigen in serum as a screening test for prostate cancer","volume":"324","author":"Catalona","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2006.12.022_bib8","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0022-5347(17)35233-3","article-title":"Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men","volume":"151","author":"Catalona","year":"1994","journal-title":"J. Urol."},{"key":"10.1016\/j.canlet.2006.12.022_bib9","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence \u2013 SEER 17 Regs Public-Use, Nov 2005 Sub (1973-2003 varying), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2006, based on the November 2005 submission. Accessed August 28, 2006."},{"key":"10.1016\/j.canlet.2006.12.022_bib10","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1056\/NEJMoa031918","article-title":"Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0ng per milliliter","volume":"350","author":"Thompson","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2006.12.022_bib11","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/aje\/kwj213","article-title":"Reduction of prostate cancer mortality in Tyrol, Austria, after introduction of prostate-specific antigen testing","volume":"164","author":"Oberaigner","year":"2006","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.canlet.2006.12.022_bib12","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1158\/1055-9965.EPI-04-0522","article-title":"Geographic patterns of prostate cancer mortality and variations in access to medical care in the United States","volume":"14","author":"Jemal","year":"2005","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.canlet.2006.12.022_bib13","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/jama.281.17.1591","article-title":"Natural history of progression after PSA elevation following radical prostatectomy","volume":"281","author":"Pound","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.canlet.2006.12.022_bib14","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canlet.2006.12.022_bib15","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jama.270.8.948","article-title":"Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening","volume":"270","author":"Catalona","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.canlet.2006.12.022_bib16","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1001\/jama.276.16.1309","article-title":"Longitudinal screening for prostate cancer with prostate-specific antigen","volume":"276","author":"Smith","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.canlet.2006.12.022_bib17","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1001\/jama.277.18.1452","article-title":"Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0ng\/mL and benign prostate examination. Enhancement of specificity with free PSA measurements","volume":"277","author":"Catalona","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.canlet.2006.12.022_bib18","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.urology.2005.01.008","article-title":"Preoperative PSA and progression-free survival after radical prostatectomy for Stage T1c disease","volume":"66","author":"Antenor","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.canlet.2006.12.022_bib19","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.urology.2005.05.025","article-title":"Detection rates and biologic significance of prostate cancer with PSA less than 4.0ng\/mL: observation and clinical implications from Tyrol screening project","volume":"66","author":"Pelzer","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.canlet.2006.12.022_bib20","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/S0022-5347(17)32369-8","article-title":"The pathological features and prognosis of prostate cancer detectable with current diagnostic tests","volume":"152","author":"Ohori","year":"1994","journal-title":"J. Urol."},{"key":"10.1016\/j.canlet.2006.12.022_bib21","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0022-5347(05)00327-7","article-title":"Pathological characteristics of prostate cancer detected through prostate specific antigen based screening","volume":"175","author":"Loeb","year":"2006","journal-title":"J. Urol."},{"key":"10.1016\/j.canlet.2006.12.022_bib22","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/jnci\/dji205","article-title":"Prostate-specific antigen levels in the United States: implications of various definitions for abnormal","volume":"97","author":"Welch","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2006.12.022_bib23","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.urology.2005.08.040","article-title":"Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years old","volume":"67","author":"Loeb","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.canlet.2006.12.022_bib24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/jama.273.4.289","article-title":"A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer","volume":"273","author":"Gann","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.canlet.2006.12.022_bib25","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/jnci\/djj307","article-title":"Effect of finasteride on the sensitivity of PSA for detecting prostate cancer","volume":"98","author":"Thompson","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2006.12.022_bib26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa032975","article-title":"Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy","volume":"351","author":"D\u2019Amico","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2006.12.022_bib27","first-page":"222","article-title":"A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer","volume":"51","author":"Stenman","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2006.12.022_bib28","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/clinchem\/37.9.1618","article-title":"Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin","volume":"37","author":"Lilja","year":"1991","journal-title":"Clin. Chem."},{"key":"10.1016\/j.canlet.2006.12.022_bib29","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0090-4295(00)00637-3","article-title":"Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging","volume":"56","author":"Catalona","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.canlet.2006.12.022_bib30","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/S0022-5347(05)67646-X","article-title":"Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer","volume":"163","author":"Brawer","year":"2000","journal-title":"J. Urol."},{"key":"10.1016\/j.canlet.2006.12.022_bib31","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/clinchem\/48.8.1198","article-title":"Human tissue kallikreins: a family of new cancer biomarkers","volume":"48","author":"Diamandis","year":"2002","journal-title":"Clin. Chem."},{"key":"10.1016\/j.canlet.2006.12.022_bib32","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1093\/clinchem\/45.11.1960","article-title":"The combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA","volume":"45","author":"Magklara","year":"1999","journal-title":"Clin. Chem."},{"key":"10.1016\/j.canlet.2006.12.022_bib33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0090-4295(99)00372-6","article-title":"\u201cBPSA,\u201d a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia","volume":"55","author":"Mikolajczyk","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.canlet.2006.12.022_bib34","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1097\/01.ju.0000095460.12999.43","article-title":"Serum pro prostate specific antigen improves cancer detection compared to free and complexed prostate specific antigen in men with prostate specific antigen 2 to 4.0ng\/ml","volume":"170","author":"Catalona","year":"2003","journal-title":"J. Urol."},{"key":"10.1016\/j.canlet.2006.12.022_bib35","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0090-4295(02)02398-1","article-title":"Proenzyme psa for the early detection of prostate cancer in the 2.5\u20134.0ng\/ml total psa range: preliminary analysis","volume":"61","author":"Sokoll","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.canlet.2006.12.022_bib36","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1097\/01.ju.0000127737.94221.3e","article-title":"Serum pro-prostate specific antigen preferentially detects aggressive prostate cancers in men with 2 to 4.0ng\/ml prostate specific antigen","volume":"171","author":"Catalona","year":"2004","journal-title":"J. Urol."},{"key":"10.1016\/j.canlet.2006.12.022_bib37","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000463885","article-title":"Correlation between prostate-specific antigen and prostate volume, evaluated by transrectal ultrasonography: usefulness in diagnosis of prostate cancer","volume":"18","author":"Veneziano","year":"1990","journal-title":"Eur. Urol."},{"key":"10.1016\/j.canlet.2006.12.022_bib38","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0022-5347(17)37393-7","article-title":"Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer","volume":"147","author":"Benson","year":"1992","journal-title":"J. Urol."},{"key":"10.1016\/j.canlet.2006.12.022_bib39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/01.ju.0000145883.01068.5f","article-title":"Accuracy of prostate weight estimation by digital rectal examination versus transrectal ultrasonography","volume":"173","author":"Loeb","year":"2005","journal-title":"J. Urol."},{"key":"10.1016\/j.canlet.2006.12.022_bib40","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1001\/jama.267.16.2215","article-title":"Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease","volume":"267","author":"Carter","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.canlet.2006.12.022_bib41","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0022-5347(17)32528-4","article-title":"Rate of change in serum prostate specific antigen levels as a method for prostate cancer detection","volume":"152","author":"Smith","year":"1994","journal-title":"J. Urol."},{"key":"10.1016\/j.canlet.2006.12.022_bib42","unstructured":"X. Yu, S. Loeb, M. Han, B.K. Suarez, K.A. Roehl, W.J. Catalona, The association between total PSA and PSA velocity, J Urol, in press."},{"key":"10.1016\/j.canlet.2006.12.022_bib43","unstructured":"S. Loeb, K.A. Roehl, W.J. Catalona, R.B. Nadler. PSA velocity threshold for predicting prostate cancer in young men. J. Urol., in press."},{"key":"10.1016\/j.canlet.2006.12.022_bib44","unstructured":"National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Prostate Cancer Early Detection. http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/prostate_detection. pdf. Accessed October 1, 2006."},{"key":"10.1016\/j.canlet.2006.12.022_bib45","doi-asserted-by":"crossref","first-page":"6157","DOI":"10.1200\/JCO.2005.01.2336","article-title":"Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy","volume":"23","author":"Patel","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2006.12.022_bib46","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/jama.294.4.440","article-title":"Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy","volume":"294","author":"D\u2019Amico","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.canlet.2006.12.022_bib47","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0090-4295(99)80383-5","article-title":"Variability of repeated serum prostate-specific antigen (PSA) measurements within less than 90 days in a well-defined patient population","volume":"47","author":"Roehrborn","year":"1996","journal-title":"Urology"},{"key":"10.1016\/j.canlet.2006.12.022_bib48","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1097\/01.ju.0000127736.86597.e7","article-title":"Variation in prostate specific antigen results from 2 different assay platforms: clinical impact on 2304 patients undergoing prostate cancer screening","volume":"171","author":"Link","year":"2004","journal-title":"J. Urol."},{"key":"10.1016\/j.canlet.2006.12.022_bib49","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1373\/clinchem.2005.059170","article-title":"Interchangeability of measurements of total and free prostate-specific antigen in serum with 5 frequently used assay combinations: an update","volume":"52","author":"Stephan","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.canlet.2006.12.022_bib50","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ijrobp.2006.01.053","article-title":"Predictors of mortality after prostate-specific antigen failure","volume":"65","author":"D\u2019Amico","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canlet.2006.12.022_bib51","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1097\/01.ju.0000181209.37013.99","article-title":"Preoperative prostate specific antigen doubling time and velocity are strong and independent predictors of outcomes following radical prostatectomy","volume":"174","author":"Sengupta","year":"2005","journal-title":"J. Urol."},{"key":"10.1016\/j.canlet.2006.12.022_bib52","unstructured":"Screening for prostate cancer, American College of Physicians, Ann. Intern. Med. 126 (1997) 480."},{"key":"10.1016\/j.canlet.2006.12.022_bib53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3322\/canjclin.53.1.27","article-title":"American Cancer Society guidelines for the early detection of cancer, 2003","volume":"53","author":"Smith","year":"2003","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2006.12.022_bib54","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0090-4295(00)00993-6","article-title":"Prostate-specific antigen best practice policy\u2013part I: early detection and diagnosis of prostate cancer","volume":"57","author":"Carroll","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.canlet.2006.12.022_bib55","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0090-4295(98)00241-6","article-title":"Measurement of complexed PSA improves specificity for early detection of prostate cancer","volume":"52","author":"Brawer","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.canlet.2006.12.022_bib56","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/sj.pcan.4500614","article-title":"Use of early PSA velocity to predict eventual abnormal PSA values in men at risk for prostate cancer","volume":"6","author":"Riffenburgh","year":"2003","journal-title":"Prostate Cancer Prostatic Dis."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383506006963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383506006963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T04:25:04Z","timestamp":1628396704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383506006963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0304383506006963"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2006.12.022","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}